acyclovir

Product NDC: 70518-1332
11-digit product format: 705181332
Labeler code: 70518
Product ID: 70518-1332_e3c767ec-60df-6be0-e053-2995a90a3e05
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: acyclovir
Dosage form: TABLET
Route: ORAL
Labeler: REMEDYREPACK INC.
Application: ANDA204314
Marketing category: ANDA
Marketing start: 2018-07-30
Marketing end: 0000-00-00
Substance: ACYCLOVIR
Active strength: 400 mg/1
Pharmacologic classes: DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X4HES1O11F	ACYCLOVIR	59277-89-3	ACYCLOVIR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
70518-1332-1	70518133201	21 TABLET in 1 BOTTLE, PLASTIC (70518-1332-1)	21 tablet	2018-08-08	0000-00-00	No	No	Current
70518-1332-2	70518133202	30 TABLET in 1 BLISTER PACK (70518-1332-2)	30 tablet	2018-08-22	0000-00-00	No	No	Current